All Posts Tagged With: "GPRO"
(AKRX) Company News for June 07, 2011 – Corporate Summary
• Share prices of home nursing provider Amedisys, Inc.(NASDAQ:AMED) fell 7.41% after CRT Capital reduced its earnings estimates for fiscal 2011
• According to Canaccord Genuity, data from a trial of...
(AWK) Company News for May 27, 2011 – Corporate Summary
• Big Lots, Inc. (NYSE:BIG) reported Q1 EPS of $0.70, above the Zacks Consensus Estimates of $0.68 per share. Revenues for the quarter fell 0.6% year-over-year to $1.23 billion, lower than the Zacks Consensus Estimate...
(GPRO) Gen-Probe Files Pre-market Approval Application for Prostate Cancer Test
Diagnostic products maker Gen-Probe Inc. (GPRO) has submitted a Pre-market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its PROGENSA PCA3 assay, a novel molecular test designed...
(GPRO) Gen-Probe’s Earnings Report Leaps Ahead of Forecast
Diagnostic product maker Gen-Probe Inc. (GPRO) announced second-quarter fiscal 2010 adjusted earnings of 52 cents per share, exceeding the Zacks Consensus Estimate of 49 cents and the year-ago earnings of...
(GPRO) Gen-Probe Invests $50 Million in Pacific Biosciences
Diagnostic product maker Gen-Probe Inc (GPRO) has made a $50 million strategic investment in privately-held DNA sequencing firm Pacific Biosciences (PacBio). The companies will collaborate on developing...
(NEOG) Neogen’s Earnings Inches Past Estimates
Neogen Corp. (NEOG) posted fiscal 2010 third-quarter results on Monday. The company’s net income recorded a strong growth of 37.5% to $3.9 million, or 17 cents per share from $2.8 million, or 12 cents per...
(NEOG) Neogen Beats Earnings Expectations by a Penny
Neogen Corp. (NEOG) recently posted fiscal second quarter results. The company’s GAAP net income grew 18% to $4.6 million, compared to $3.9 million in the year-ago period. Adjusting for a 3-for-2 stock...
(GPRO) Gen-Probe Earns U.S. Food and Drug Administration Approval
Recently, Gen-Probe Inc. (GPRO) announced that it has received the green light from the U.S. Food and Drug Administration (FDA) to market ProParaflu Plus assay. The assay, developed by Prodesse, a wholly-owned...
(GPRO) Millipore & Roka to Collaborate
On Monday, Millipore Corp. (MIL) announced its collaboration with Roka Bioscience Inc. to develop molecular assays and portable instruments for biopharmaceutical production.
Roka Bioscience is a new, independent company created following the spin-off...